Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare's strong performance is underscored by its record Marketplace utilization growth, with Medical Loss Ratio (MLR) increasing by 10.2% quarter-over-quarter, reaching 95.6% in the third quarter of 2025. Furthermore, the company's Medicare Advantage margins have also improved, rising by 360 basis points to 93.6% during the same period, with expectations for further positive trends in upcoming years. Given its extensive Medicaid contracts, particularly in key states, and potential for new market opportunities, Molina Healthcare is well-positioned for continued financial growth and improved margins.

Molina Healthcare's recent financial performance has revealed a significant earnings shortfall in 4Q25, with EPS coming in at ($2.75)—a $3 deviation from expectations, primarily attributed to Medicaid retroactive items and ongoing trend pressures. The company is anticipated to experience margin compression in its Medicaid segment, forecasting a decline to 1.2% in 2026, contrasting unfavorably with competitors like UnitedHealth and Elevance Health. Additionally, projections indicate a potential 2.6% year-over-year decline in Medicaid membership, compounded by pressures in both the Medicaid and Marketplace segments, resulting in lowered adjusted EPS estimates for 2026 and 2027.